- The US is pushing to tie drug prices to foreign rates, amid global trends of price controls and health technology assessments.
- Europe is exploring drug pricing proposals with the Trump administration amid pressure over drug costs and tariffs.
The administration announced new tariffs on foreign drug manufacturers, impacting the global pharmaceutical industry.
1 report, 1 independent
Updated Jun 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The administration announced new tariffs on foreign drug manufacturers, impacting the global pharmaceutical industry.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Pfizer and other companies are facing administration policy guidance regarding higher drug prices abroad in exchange for revenue sharing with HHS.Sub-event
Trump administration announces new tariffs on foreign drug manufacturers.1 source
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Related events
- Donald Trump threatens a 100% tax on imports from European countries while also promising protection for US companies from foreign digital service taxes.
- Trump's tariff threats are complicating Canada's trade goals and putting the strategic partnership with China under scrutiny.
- Trump imposes tariffs on countries buying Russian energy, while India seeks to leverage the situation for its exporters.
- Tariffs implemented by Trump are reportedly affecting companies in the state of Michigan.
- Donald Trump signed an Executive Order easing tariffs, which boosts bilateral trade between the US and India.